Company ProfilePremium

NattoPharma

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
NattoPharma - Healthcare showcase

Year Founded & Workforce

2004

50 Employees

Industry

Healthcare

Services

Health Solutions
N

NattoPharma Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

NattoPharma Overview

Company Headquarters: Oslo, Norway

Founded: 2004

Workforce: 11-50

Company Working: NattoPharma is a global leader in the vitamin K2 dietary supplement segment. The company is into the creation and introduction of novel health ingredients and has collaborated with other companies for the distribution of its products. The company offers products related to health ingredients under business segment brands and services. It also offers research and development services to other companies and helps them in clinical trials associated with vitamin K2.

Strategy

NattoPharma has a strategy for the continuous research and development of its blockbuster product. For the success of its blockbuster product, the company invests in sales and marketing activities. It is also engaged in increasing its presence in emerging markets. Currently, the company is a major multinational player in Brazil, China, India, and the US.

Company Snapshot

$6,100M

Revenue

50

Employees

2004

Founded

Oslo, Norway

Headquarters

SWOT Analysis

Strengths

  • Unique and innovative products
  • Huge customer base
  • Large distribution channel
  • Strong marketing strategies

Weaknesses

  • Increasing cost of operations
  • Dependent on one product for revenue generation

Opportunities

  • Extended healthcare needs
  • New product development
  • Acquisitions and in-licensing development opportunities

Threats

  • Patent infringements
  • Stringent regulation policies
  • Increasing competition

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Product Offering

  • NattoPharma
    • Health Solutions

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Global Sales rose from USD 6,100 Mn in 2016 to USD 7,739 Mn in 2017.
NattoPharma — By Business Segment
Series (USD Mn)20162017
Global Sales6,1007,739

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.